Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Competition For High-End Medical Device Market In China Heats Up

This article was originally published in PharmAsia News

Executive Summary

MNCs have cornered the high-end medical device market in China. Siemens, Philips and Fujifilm Medical Systems monopolize the diagnostic devices sector, while Cook Medical, Medtronic and Johnson & Johnson Medical occupy the intervention and surgery devices market. With the imminent implementation of the China health care reform, a fresh round of battle among suppliers looms. Most foreign medical device companies usually sell products via agents, at the expense of market control and hiked-up pricing. To address this, Cook Medical discloses plans to directly handle hospital sales, and will first focus on large hospitals in major cities. This will cut high-end medical device prices by 30 percent, which promises a big impact on the sector. (Click here for more - Chinese Language)

You may also be interested in...

Warning Letter Close-Outs – October 2020

The US FDA issued only one device-related close-out letter in October.

Compounding Pharmacies Sue FDA For Conflating Out-Of-State Dispensing And Distribution In MOU

Seven pharmacies have filed a lawsuit against the FDA claiming the agency exceeded its statutory authority in its final standard memorandum of understanding on interstate compounding and that the MOU will have an adverse impact on compounding pharmacies and patients.

What COVID Spotlight Means For Pharma – In Their Own Words

Several experts spoke with Scrip about their take on how the biopharmaceutical industry's efforts to respond to COVID-19 might help industry's image problem. 




Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts